1. Home
  2. DCBO vs MDXG Comparison

DCBO vs MDXG Comparison

Compare DCBO & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCBO
  • MDXG
  • Stock Information
  • Founded
  • DCBO 2016
  • MDXG 2006
  • Country
  • DCBO Canada
  • MDXG United States
  • Employees
  • DCBO N/A
  • MDXG N/A
  • Industry
  • DCBO
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • DCBO
  • MDXG Health Care
  • Exchange
  • DCBO Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • DCBO 1.3B
  • MDXG 1.3B
  • IPO Year
  • DCBO 2020
  • MDXG N/A
  • Fundamental
  • Price
  • DCBO $41.80
  • MDXG $8.57
  • Analyst Decision
  • DCBO Strong Buy
  • MDXG Strong Buy
  • Analyst Count
  • DCBO 7
  • MDXG 5
  • Target Price
  • DCBO $54.71
  • MDXG $12.00
  • AVG Volume (30 Days)
  • DCBO 60.8K
  • MDXG 617.6K
  • Earning Date
  • DCBO 02-28-2025
  • MDXG 02-26-2025
  • Dividend Yield
  • DCBO N/A
  • MDXG N/A
  • EPS Growth
  • DCBO 1403.35
  • MDXG N/A
  • EPS
  • DCBO 0.56
  • MDXG 0.52
  • Revenue
  • DCBO $209,170,000.00
  • MDXG $342,804,000.00
  • Revenue This Year
  • DCBO $21.91
  • MDXG $9.56
  • Revenue Next Year
  • DCBO $14.25
  • MDXG $9.19
  • P/E Ratio
  • DCBO $75.31
  • MDXG $16.49
  • Revenue Growth
  • DCBO 22.67
  • MDXG 10.93
  • 52 Week Low
  • DCBO $33.81
  • MDXG $5.47
  • 52 Week High
  • DCBO $56.41
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • DCBO 37.06
  • MDXG 41.31
  • Support Level
  • DCBO $40.13
  • MDXG $8.29
  • Resistance Level
  • DCBO $43.84
  • MDXG $9.30
  • Average True Range (ATR)
  • DCBO 1.10
  • MDXG 0.30
  • MACD
  • DCBO 0.06
  • MDXG -0.04
  • Stochastic Oscillator
  • DCBO 41.98
  • MDXG 27.10

About DCBO Docebo Inc.

Docebo Inc is a provider of cloud-based learning management systems.. The solutions provided by the company are sold on a subscription model and subscriptions are typically structured with an initial fixed term of between one and three years, without the ability for customers to terminate for convenience. The company charges its customers based on a per-learner, per-module basis, varying depending on the size of the organization and complexity. The majority of the revenue is derived from customers based in North America.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: